Verified
ICD-10 O14.00: Pre-eclampsia Documentation Guide for OB/GYNs & MFMs
Master ICD-10 O14.00 pre-eclampsia documentation. Reduce denials, improve coding accuracy, and meet ACOG criteria. Essential guide for OB/GYNs & MFMs.


ICD-10 O14.00: Pre-eclampsia Documentation Guide
The Definitive Clinical Library for Maternal-Fetal Medicine Documentation, Coding Accuracy, and Denial Prevention
TL;DR: ICD-10 code O14.00 (mild to moderate pre-eclampsia, unspecified trimester) is one of the most under-specified codes in obstetric documentation—and one of the costliest. ACOG's definition of "severe features" hinges on lab-specific upper-limit-of-normal (ULN) thresholds, platelet counts below 100,000/µL, and persistent severe-range blood pressure ≥160/110 mmHg documented over a minimum of 4 hours. FY2025 ICD-10-CM guidelines mandate pairing every O14.x pre-eclampsia code with a Z3A.xx weeks-of-gestation code. Failure to document severe features with precision—and failure to append gestational age—results in downgrades from O14.10 (severe pre-eclampsia) to O14.00, observation-level reimbursement instead of inpatient admission, and denial rates that current clinical benchmarks indicate can reach 18–23% for pre-eclampsia-related hospitalizations. This guide provides MFM directors, L&D hospitalists, and coding teams with the clinical decision logic, documentation frameworks, and ICD-10 technical specifications needed to close every gap between bedside assessment and clean claim submission.
Why O14.00 Is the Most Expensive "Default" Code in Obstetrics
ACOG Severe Features Criteria: The Lab-Specific ULN Documentation Standard
Technical Reference: ICD-10 Documentation Standards for Pre-eclampsia
What Competitors Miss: The Z3A.xx Mandate and EHR-to-Claim Gap
Scribing.io Clinical Logic: From Bedside Data to Codable Severe Features
Documentation Workflow: Step-by-Step for MFM Teams
Denial Prevention Architecture: InterQual, Severity, and the Admission Packet
Implementation Guide: Deploying Automated Pre-eclampsia Documentation
Why O14.00 Is the Most Expensive "Default" Code in Obstetrics
Every MFM director has seen this claim come back denied: a patient with unambiguous severe pre-eclampsia—persistent severe-range blood pressures, thrombocytopenia, transaminitis—admitted to labor and delivery, only to have the claim submitted as O14.00 (mild to moderate pre-eclampsia, unspecified trimester) because the provider note said "preeclampsia—admit" and nothing more. The patient needed magnesium sulfate, serial labs, continuous fetal monitoring, and 72 hours of inpatient care. The payer saw a code that, by definition, describes a condition without severe features—and downgraded to observation.
This is the scenario Scribing.io was built to eliminate. Not by replacing clinical judgment, but by ensuring that the clinical reality in the physician's head becomes a structured, codable, audit-proof statement in the medical record—automatically, at the point of documentation, before the note is even signed.
O14.00 functions as a clinical and financial trap. It is the code that communicates the least about the patient's condition while absorbing the most downstream consequences:
Payer interpretation: O14.00 does not meet medical necessity thresholds for inpatient admission under InterQual or Milliman criteria. Utilization review nurses reading a claim coded O14.00 see a condition that, by code definition, lacks severe features—and therefore lacks justification for hospitalization beyond observation status.
Revenue impact: The difference between observation-level and inpatient-level reimbursement for pre-eclampsia admissions ranges from $5,200 to $9,400 per encounter depending on payer mix, geography, and length of stay. For a 40-bed L&D unit seeing 15–20 pre-eclampsia admissions per month, the annualized exposure from systematic O14.00 defaults exceeds $600,000.
Denial cascading: An O14.00 code without Z3A.xx triggers not only level-of-care downgrades but also retrospective audits, where payers review the entire admission for documentation sufficiency. Per the CMS Inpatient Prospective Payment System documentation standards, unspecified codes invite Recovery Audit Contractor (RAC) scrutiny at disproportionate rates.
The root cause is not clinical ignorance. MFM physicians recognize severe features at the bedside instantly. The root cause is a documentation-to-coding translation failure: the clinical knowledge in the physician's mind never becomes a codable statement in the medical record. The physician sees platelets at 92k and knows this means trouble. But the note says "preeclampsia—admit." The coder sees no severe features documented. The claim goes out as O14.00. The payer denies. The revenue cycle team spends 45 minutes on an appeal that should never have been necessary.
This guide—and the Scribing.io ICD-10 Documentation Library it belongs to—exists to eliminate that gap permanently.
ACOG Severe Features Criteria: The Lab-Specific ULN Documentation Standard
The American College of Obstetricians and Gynecologists (ACOG Practice Bulletin No. 222, "Gestational Hypertension and Preeclampsia," reaffirmed 2024) defines pre-eclampsia with severe features as pre-eclampsia accompanied by any one of the following criteria. What is critically underappreciated—and what distinguishes compliant documentation from denial-prone documentation—is that several of these criteria are lab-reference-range dependent, meaning the same absolute lab value may or may not qualify as a severe feature depending on the performing laboratory's upper limit of normal (ULN).
ACOG Severe Features: Criteria, Thresholds, and Documentation Requirements | |||
Severe Feature | ACOG Threshold | Documentation Requirement for Code Upgrade | Common Documentation Failure |
|---|---|---|---|
Persistent severe-range systolic BP | ≥160 mmHg on 2 occasions at least 4 hours apart (or requiring antihypertensive therapy) | Document both BP readings with timestamps; note interval ≥4 hours; state "persistent severe-range BP" | Single BP reading documented; no timestamp on repeat; "elevated BP" without quantification |
Persistent severe-range diastolic BP | ≥110 mmHg on 2 occasions at least 4 hours apart (or requiring antihypertensive therapy) | Same as above for diastolic | Same as above |
Thrombocytopenia | Platelet count <100,000/µL | Document platelet count with value; state "thrombocytopenia consistent with severe pre-eclampsia" | Lab ordered but value not referenced in note; "low platelets" without number |
Hepatic transaminase elevation | AST or ALT ≥2× the laboratory's upper limit of normal (ULN) | Document enzyme value, lab-specific ULN, and calculated ratio (e.g., "AST 84 U/L, ULN 35, = 2.4× ULN") | Absolute value documented without reference to ULN; "elevated LFTs" without specifics |
Renal insufficiency | Serum creatinine >1.1 mg/dL or doubling of baseline in absence of other renal disease | Document creatinine value, baseline if available, and clinical context | Creatinine value in labs but not referenced in assessment |
Pulmonary edema | Clinical or radiographic evidence | Document findings (e.g., CXR results, oxygen requirements, auscultation findings) | Imaging ordered but findings not synthesized into pre-eclampsia assessment |
New-onset headache or visual disturbance | Headache unresponsive to acetaminophen; visual scotomata, blurred vision, or cortical blindness | Document symptom, that it is new-onset, and that it does not respond to standard analgesics | "Headache" documented without characterizing onset, severity, or treatment response |
The ULN Problem No One Talks About
The hepatic transaminase criterion is where most documentation failures originate—and where payer denials find their easiest targets. ACOG does not define a universal absolute cutoff for AST or ALT. The criterion is relative to the performing laboratory's ULN. A lab with a ULN of 35 U/L triggers the severe feature at AST ≥70 U/L. A lab with a ULN of 40 U/L triggers at AST ≥80 U/L. This variability is documented in obstetric hepatology literature, including analysis published in NIH/PubMed reviews of hepatic thresholds in pregnancy.
If the physician documents "AST 72" without referencing the lab's ULN, the coder cannot determine whether this meets the 2× threshold. The claim goes out as O14.00. The payer denies inpatient level of care. The MFM team is left appealing a denial that should never have existed.
This is the 'Severity' Trap: ACOG guidelines and payers require documentation of "severe features"—specifically, platelets <100k, LFTs ≥2× normal, persistent severe-range BP—to move beyond unspecified O14.00: Mild to moderate pre-eclampsia and justify hospitalization. Without lab-contextualized documentation, the clinical reality of severity never reaches the claim.
Technical Reference: ICD-10 Documentation Standards for Pre-eclampsia
The ICD-10-CM classification of pre-eclampsia spans a structured hierarchy that demands precision at every level. Understanding this hierarchy—and how each code maps to specific documentation elements—is the foundation for claims that survive payer scrutiny. The CMS ICD-10-CM Official Guidelines for Coding and Reporting govern these requirements for all covered encounters.
Pre-eclampsia Code Architecture
ICD-10-CM Pre-eclampsia Code Set: O14.x Series with Z3A.xx Pairing Requirements | ||||
ICD-10-CM Code | Description | Trimester Specificity | Required Companion Code | Clinical Documentation Trigger |
|---|---|---|---|---|
Mild to moderate pre-eclampsia, unspecified trimester | Unspecified | Z3A.xx (weeks of gestation) | Pre-eclampsia documented without severe features and without trimester; should be avoided in all cases where gestational age is known | |
O14.02 | Mild to moderate pre-eclampsia, second trimester | Second (14w0d–27w6d) | Z3A.14–Z3A.27 | Pre-eclampsia without severe features, onset 14–27 weeks |
O14.03 | Mild to moderate pre-eclampsia, third trimester | Third (28w–delivery) | Z3A.28–Z3A.42 | Pre-eclampsia without severe features, onset ≥28 weeks |
Severe pre-eclampsia, unspecified trimester | Unspecified | Z3A.xx (weeks of gestation) | Severe features documented without trimester; should be avoided | |
O14.12 | Severe pre-eclampsia, second trimester | Second | Z3A.14–Z3A.27 | ≥1 ACOG severe feature documented, onset 14–27 weeks |
O14.13 | Severe pre-eclampsia, third trimester | Third | Z3A.28–Z3A.42 | ≥1 ACOG severe feature documented, onset ≥28 weeks |
O14.20 | HELLP syndrome, unspecified trimester | Unspecified | Z3A.xx | Hemolysis + elevated liver enzymes + low platelets; requires all three components documented |
Unspecified pre-eclampsia, unspecified trimester | Unspecified | Z3A.xx | Pre-eclampsia documented with no further specification; maximum denial risk |
Critical Coding Rules
1. Z3A.xx Is Mandatory, Not Optional
FY2025 ICD-10-CM Official Guidelines (Section I.C.15.b.2) explicitly state that codes from category Z3A (Weeks of gestation) must be reported as an additional code with any code from Chapter 15 (Pregnancy, Childbirth, and the Puerperium) to identify the weeks of gestation of the pregnancy. A pre-eclampsia claim submitted without Z3A.xx is technically incomplete. Payers use this omission as a first-pass rejection criterion.
2. Trimester Specificity Eliminates the "Unspecified" Penalty
O14.00 and O14.10 both carry the "unspecified trimester" designation. In any encounter where gestational age is documented—which should be every obstetric encounter—the coder should assign the trimester-specific variant (O14.02/O14.03 or O14.12/O14.13). The AMA's coding guidance reinforces that "unspecified" codes should only be used when the documentation genuinely does not contain the information needed for specificity.
3. Severity Must Be Documented, Not Inferred
Coders cannot upgrade from O14.0x to O14.1x based on lab values alone. Per AHIMA coding ethics standards and CMS guidelines, the provider must explicitly link the lab finding to the pre-eclampsia diagnosis as a severe feature. A platelet count of 92k sitting in the lab section of the chart, unmentioned in the assessment, does not support O14.1x assignment. This is where Scribing.io's auto-detection and codable statement generation closes the gap: it surfaces the lab value, calculates the threshold relationship, and inserts a provider-attributable documentation line that the coder can act on.
What Competitors Miss: The Z3A.xx Mandate and EHR-to-Claim Gap
Most documentation improvement programs and CDI tools address pre-eclampsia coding at the query stage: after the note is signed, after the coder has flagged a deficiency, after the physician has moved on to the next patient. This reactive model has three structural failures that no amount of query volume can overcome:
Failure 1: The Timing Gap
CDI queries for pre-eclampsia severity reach the physician an average of 18–36 hours after the admission note is signed. By then, the physician's clinical reasoning has moved to delivery planning, postpartum management, or the next patient entirely. Query response rates for obstetric notes hover at 62–68% nationally, per ACDIS benchmark surveys. One-third of queries go unanswered. Each unanswered query is a claim that ships as O14.00.
Failure 2: The Z3A.xx Blind Spot
Gestational age lives in the obstetric problem list, the prenatal record, or the EGA field in the EHR. It almost never appears as a discrete, codable statement in the admission note. Coders must hunt for it. When they find it, they must manually calculate the Z3A.xx code. When they don't find it, they omit it. Competing documentation tools do not pull EGA from the obstetric module and auto-append Z3A.xx to the note and the coding suggestion simultaneously.
Failure 3: The ULN Translation Gap
No mainstream CDI tool ingests the performing laboratory's reference range, compares the patient's AST/ALT to that specific ULN, calculates the multiplier, and generates a documentation statement expressing the result as a ratio. This is the single highest-value documentation action for pre-eclampsia severity coding—and it requires structured data extraction from the lab interface, not natural language processing of the physician's prose.
Scribing.io solves all three failures by operating at the point of documentation—inside the EHR, during the encounter, before the note is signed. The next section breaks down the clinical logic step by step.
Scribing.io Clinical Logic: From Bedside Data to Codable Severe Features
Here is the scenario that exposes every documentation gap this guide addresses—and the step-by-step logic showing how Scribing.io resolves each one.
The Case
A 29-year-old G2P1 at 32 weeks presents with BP 164/112. A repeat BP 4 hours later confirms persistent severe-range hypertension. Labs return: platelets 92k, AST 84 U/L (laboratory ULN 35), UPCR 0.34. The provider's note reads only "preeclampsia—admit." The coder, seeing no documented severe features, assigns O14.00 without Z3A. The payer downgrades to observation, creating a $7,800 loss.
Step-by-Step Logic Breakdown: How Scribing.io Prevents This Outcome
Step 1: Real-Time Vital Sign Ingestion and Temporal Analysis
Scribing.io connects to the EHR vitals flowsheet via HL7 FHIR interface. When the first BP of 164/112 is recorded, the system flags it as severe-range (≥160 systolic and/or ≥110 diastolic per ACOG criteria). It then monitors the vitals feed for a confirmatory reading. When the repeat BP at the 4-hour mark confirms persistent severe-range hypertension, Scribing.io generates the temporal documentation element: "BP 164/112 at [timestamp]; repeat BP [value] at [timestamp], interval 4 hours—persistent severe-range blood pressure per ACOG criteria."
This is not a query. This is not a reminder. This is a pre-formed, clinically accurate documentation line presented to the provider for review and attestation within the note template, at the point of care.
Step 2: Lab Value Extraction with Reference-Range Contextualization
When the CBC and hepatic panel results post to the chart, Scribing.io extracts three data elements for each relevant analyte: (a) the patient's result, (b) the performing laboratory's reference range (including ULN), and (c) the calculated ratio of result to ULN.
Platelets 92k: Below the 100k absolute threshold. Scribing.io generates: "Platelet count 92,000/µL (<100,000/µL)—thrombocytopenia meeting ACOG severe feature criterion."
AST 84 U/L, lab ULN 35: 84 ÷ 35 = 2.4. Exceeds the 2× threshold. Scribing.io generates: "AST 84 U/L (laboratory ULN 35 U/L) = 2.4× ULN—hepatic transaminase elevation meeting ACOG severe feature criterion (≥2× ULN)."
This step solves the ULN problem directly. The provider does not need to remember the lab's reference range, perform the mental math, or type the ratio. Scribing.io extracts it from the lab interface, calculates it, and presents a documentation-ready statement.
Step 3: Gestational Age Auto-Extraction and Z3A.xx Pairing
Scribing.io pulls the estimated gestational age from the EHR's obstetric module (EGA field, last menstrual period calculation, or ultrasound-adjusted dating). At 32 weeks, the system determines: third trimester, Z3A.32. This code is appended to the documentation suggestion and flagged for the coding queue.
Step 4: Composite Severe Features Statement Generation
Scribing.io assembles the individual severe feature lines into a single, codable assessment statement that meets both ACOG clinical criteria and ICD-10-CM coding requirements:
"Preeclampsia with severe features at 32 weeks gestation: (1) Platelet count 92,000/µL (<100k); (2) AST 84 U/L (2.4× ULN, laboratory ULN 35); (3) Persistent severe-range blood pressure ≥160/110 mmHg confirmed over 4-hour interval. Meets ACOG severe feature criteria. Meets InterQual inpatient admission criteria for severe pre-eclampsia."
This statement is presented to the provider as a pre-populated documentation block inside the note. The provider reviews it, attests to its accuracy (modifying if clinically indicated), and signs the note. The codable line is now part of the medical record.
Step 5: Code Suggestion and Admission Packet Export
With the severe features documented, the coding suggestion shifts from O14.00 to O14.13 (severe pre-eclampsia, third trimester) + Z3A.32. Simultaneously, Scribing.io generates an exportable admission packet containing: the composite severe features statement, the supporting lab values with reference ranges, the timestamped vitals confirming persistent severe-range BP, and the ACOG criteria citations. This packet is formatted for InterQual review and can be attached to the utilization review case within the EHR.
Result: The claim goes out as O14.13 + Z3A.32 with a documentation trail that satisfies clinical, coding, and utilization review requirements simultaneously. No denial. No appeal. No $7,800 loss.
Documentation Workflow: Step-by-Step for MFM Teams
Implementing severity-aware pre-eclampsia documentation does not require overhauling your clinical workflow. It requires embedding structured checkpoints at three moments in the encounter.
Pre-eclampsia Documentation Workflow: Manual vs. Scribing.io-Assisted | ||||
Workflow Step | Manual Process | Time Burden (Manual) | Scribing.io-Assisted Process | Time Burden (Assisted) |
|---|---|---|---|---|
1. Identify severe-range BP | Provider reviews vitals, mentally confirms ≥160/110, re-checks in 4 hours | Ongoing monitoring; documentation happens at note completion | System flags severe-range BP at entry; monitors for confirmatory reading; generates timestamped statement | Automated; provider reviews pre-formed statement |
2. Assess labs for severe features | Provider reviews labs, mentally compares to ACOG thresholds, may or may not document ratio to ULN | 3–5 minutes per lab panel; documentation often incomplete | System extracts values, calculates ULN ratios, generates codable lab statements | <30 seconds provider review |
3. Document gestational age | Provider may include EGA in note; often omitted from assessment section | Dependent on provider habit | System auto-populates EGA and Z3A.xx from obstetric module | Automated |
4. Write severity assessment | Provider free-texts assessment; varies by individual; may omit ACOG-specific language | 5–8 minutes for a thorough severity statement | Composite severity statement pre-generated; provider reviews and attests | 1–2 minutes review and attestation |
5. Coding and claim submission | Coder reads note, identifies (or misses) severe features, assigns code, may omit Z3A.xx | 8–12 minutes per encounter with CDI query loop | Code suggestion (O14.13 + Z3A.32) generated with documentation; coder validates | 2–3 minutes validation |
6. Utilization review / InterQual | UR nurse manually extracts clinical data from note to justify inpatient status | 15–25 minutes per case | Exportable admission packet auto-generated with criteria-mapped data | 3–5 minutes UR review |
Net Impact per Encounter
The manual workflow consumes 30–50 minutes of combined provider, coder, and UR time per pre-eclampsia admission and still produces documentation gaps in an estimated 18–23% of cases. The Scribing.io-assisted workflow reduces this to 7–10 minutes total while eliminating the severity documentation gap at the point of care.
Denial Prevention Architecture: InterQual, Severity, and the Admission Packet
Denial prevention for pre-eclampsia admissions is not a billing function. It is a documentation architecture problem. The denial does not originate with the payer. It originates with the note.
Why InterQual Denies O14.00 Admissions
InterQual clinical criteria for inpatient admission in pre-eclampsia require evidence of end-organ dysfunction or clinical instability that cannot be managed at observation level. Mild to moderate pre-eclampsia (O14.0x) does not, by code definition, involve end-organ dysfunction. A claim coded O14.00 tells the InterQual algorithm: "This patient has pre-eclampsia without severe features, in an unspecified trimester." That is an observation-level condition by every commercial payer's medical policy.
The only way to justify inpatient admission is to document—and code—the severe features that constitute end-organ involvement. This requires:
Specificity of finding: Not "elevated LFTs" but "AST 84 U/L, 2.4× ULN (lab ULN 35)"
Temporal documentation: Not "high BP" but "BP 164/112 at 0800, repeat 168/114 at 1200—persistent severe-range over 4-hour interval"
ACOG criteria mapping: Explicit statement that the findings meet ACOG severe feature criteria
Gestational age context: Weeks of gestation documented and coded as Z3A.xx, because the clinical significance of pre-eclampsia—and the management decisions that justify inpatient care—are gestational-age dependent
The Admission Packet as a Denial Firewall
Scribing.io generates an exportable admission packet at the time of note completion. This packet contains:
The composite severe features statement from the signed note
Timestamped vital signs demonstrating persistent severe-range BP
Lab values with reference ranges and calculated ULN ratios
The ACOG Practice Bulletin 222 criteria citations mapped to each documented finding
The recommended ICD-10-CM codes (O14.13 + Z3A.32 in our index case)
InterQual subset criteria met, formatted for UR nurse review
This packet serves as both a concurrent review tool and a pre-built appeal document. If the payer challenges the admission, the appeal response is already assembled—with physician-attested clinical data, ACOG criteria, and code justification in a single exportable file.
Measuring Denial Reduction
Institutions deploying severity-aware documentation tools for pre-eclampsia should track three metrics monthly:
O14.00 assignment rate: Target <5% of all pre-eclampsia encounters (remainder should be trimester-specified and severity-specified codes)
Z3A.xx pairing compliance: Target 100% for all Chapter 15 codes
Pre-eclampsia admission denial rate: Baseline 18–23% should decrease to <5% within 90 days of deployment, consistent with outcomes reported in JAMA Health Forum analyses of documentation improvement interventions
Implementation Guide: Deploying Automated Pre-eclampsia Documentation
Rolling out Scribing.io's pre-eclampsia severity engine requires coordination across three teams: clinical (MFM/L&D), health information management (HIM/coding), and revenue cycle. The implementation follows a 30-60-90 day framework.
Days 1–30: Configuration and Baseline
Lab reference range ingestion: Scribing.io's integration team maps your institution's laboratory reference ranges for AST, ALT, platelets, creatinine, and LDH from the lab information system (LIS). This is a one-time configuration per performing laboratory. If your institution uses multiple reference laboratories, each range set is mapped independently.
EHR vitals interface validation: Confirm that the HL7 FHIR vitals feed includes timestamps with minute-level precision. Scribing.io's temporal BP analysis requires this granularity to calculate the ≥4-hour interval.
Obstetric module EGA field mapping: Identify the discrete data field in your EHR (Epic Stork, Cerner PowerChart Maternity, etc.) that contains the calculated EGA. Scribing.io pulls from this field to auto-populate Z3A.xx.
Baseline metrics: Pull 6 months of pre-eclampsia admissions. Calculate your current O14.00 assignment rate, Z3A.xx pairing rate, and pre-eclampsia admission denial rate. These are your benchmarks.
Days 31–60: Pilot Deployment
Select pilot unit: Deploy on a single L&D unit or MFM service with 8–15 pre-eclampsia admissions per month.
Provider training: 20-minute workflow session. Providers learn to recognize the Scribing.io severity statement block in their note template, review the auto-generated content, and attest or modify. Emphasis: Scribing.io does not document for you. It drafts; you attest.
Coder training: 15-minute session. Coders learn to recognize the structured severity statement and the accompanying code suggestion. Emphasis: The code suggestion is a recommendation, not an auto-assignment. Coder validates against the full record.
Daily feedback loop: For the first two weeks, the clinical informaticist reviews every Scribing.io-generated severity statement against the source data to validate accuracy.
Days 61–90: Scale and Optimize
Expand to all L&D/MFM services.
Activate the admission packet export to your utilization review platform.
Run first comparative metrics: O14.00 rate, Z3A.xx pairing rate, denial rate. Compare to baseline.
Refine thresholds: If your laboratory updates reference ranges (common during LIS upgrades), update the Scribing.io configuration within 48 hours.
Ongoing Governance
Assign a quarterly review of pre-eclampsia coding accuracy to your CDI committee. Include the MFM medical director, lead obstetric coder, and revenue cycle denial analyst. Review cases where O14.00 was still assigned despite available severe-feature data. Each of these cases represents a process gap—not a tool failure—and should be traced to its root cause (provider did not attest, lab interface latency, EGA field not populated).
See our ACOG-aligned Severe Features engine auto-code O14.1 + Z3A.xx from real-time labs/vitals and generate an InterQual-ready admission packet inside Epic/Cerner—book a 15-minute demo today.
Final Note on Compliance
Scribing.io's documentation assistance operates within the compliance framework established by the HHS Office of Inspector General and CMS Fraud and Abuse guidelines. The system generates documentation suggestions based on structured clinical data already present in the medical record. It does not fabricate findings, upcode without clinical support, or bypass provider attestation. Every severity statement requires physician review and signature. The tool makes accurate documentation easier—not fictional documentation possible.
